Treatment of non-small-cell lung cancer in older persons

ONCOLOGY

Volumn 17, Issue 1, 2003, Pages 31-39

  Basche, Michele ^a   Kelly, Karen ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

AGE; AGED; AGING; CLINICAL TRIAL; FEMALE; FRAIL ELDERLY; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; MULTIMODALITY CANCER THERAPY; QUALITY OF LIFE; REVIEW; RISK FACTOR;

AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CLINICAL TRIALS; COMBINED MODALITY THERAPY; FEMALE; FRAIL ELDERLY; HUMANS; LUNG NEOPLASMS; MALE; QUALITY OF LIFE; RISK FACTORS;

EID: 0037266353     PISSN: 08909091     EISSN: 08909091     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Jemal A, Thomas A, Murray T, et al: Cancer statistics, 2001. CA Cancer J Clin 52:23- 47, 2002.
2. Yancik R, Ries LA: Aging and cancer in America: Demographic and epidemiologic perspectives. Hematol Oncol Clin North Am 14:17-23, 2000.
3. Surveillance, Epidemiology, and End Results (SEER) Program Public-Use CD-ROM (1973-1997), National Cancer Institute, DC- CPS, Cancer Surveillance Research Program, Cancer Statistics Branch, released April 2000, based on August 1999 submission.
4. Extermann M, Aapro M: Assessment of the older cancer patient. Hematol Oncol Clin North Am 14:63-77, 2000.
5. Gridelli C, Perrone F, Monfardini S: Lung cancer in the elderly. Eur J Cancer 33:2313-2314, 1997.
6. Ginsberg RJ, Vokes EE, Rosenzweig, K: Non-small cell lung cancer, in: Devita VT, Hell- man S, Rosenberg SA (eds): Cancer: Principles and Practice of Oncology, 6th ed, pp 925-983. Philadelphia, Lippincott Williams & Wilkins, 2001.
7. Muss HB: Older age-not a barrier to cancer treatment. N Engl J Med 15:1128-1129, 2001.
8. van Rens MT, de la Riviere AB, Elbers HR, et al: Prognostic assessment of 2, 361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II, and IIIA. Chest 117:374-379, 2000.
9. Ishida T, Yokoyama H, Kaneko S, et al: Long-term results of operation for non-small cell lung cancer in the elderly. Ann Thorac Surg 50:919-922, 1990.
10. Kamiyoshihara M, Kawashima O, Ish- ikawa S, et al: Long-term results after pulmonary resection in elderly patients with non-small cell lung cancer. J Cardiovasc Surg {Torino) 41:483-486, 2000.
11. Shirakusa T, Tsutsui M, Iriki N, et al: Results of resection for bronchogenic carcinoma in patients over the age of 80. Thorax 44:189-191, 1989.
12. Naunhein KS, Kesler KA, D'Orazio SA, et al: Lung cancer in the octogenarian. Eur J Cardiolhorac Surg 8:453-456, 1994.
13. Osaki T, Shirakusa T, Kodate M, et al: Surgical treatment of lung cancer in the octogenarian. Ann Thorac Surg 57:188-192, 1994.
14. Pagni S, Federico JA, Ponn RB: Pulmonary resection for lung cancer in octogenarians. Ann Thorac Surg 63:785-789, 1997.
15. Hanagiri T, Muranaka H, Hashimoto M, et al: Results of surgical treatment of lung cancer in octogenarians. Lung Cancer 23:129-133, 1999.
16. Ginsberg RJ, Hill LD, Eagan RT, et al: Modem thirty-day operative mortality for surgical resections in lung cancer. J Thorac Cardiovasc Surg 86:654-658, 1983.
17. Romano PS, Mark DH: Patient and hospital characteristics related to in-hospital mortality after lung cancer resection. Chest 101:1332-1337, 1992.
18. Harpole DH Jr, DeCamp MM Jr, Daley J, et al: Prognostic models of thirty-day mortality and morbidity after major pulmonary resection. J Thorac Cardiovasc Surg 117:969-979, 1999.
19. Bernard A, Ferrand L, Hagry O, et al: Identification of prognostic factors determining risk groups for lung resection. Ann Thorac Surg 70:1161-1167, 2000.
20. Dyszkiewicz W, Pawlak K, Gasiorowski L: Early post-pneumonectomy complication in the elderly. Eur J Cardiolhorac Surg 17:246-250, 2000.
21. de Perrot M, Licker M, Reymond MA, et al: Influence of age on operative mortality and long-term survival after lung resection for bronchogenic carcinoma. Eur Respir J 14:419-422, 1999.
22. Landreneau RJ, Sugarbaker DJ, Mack MJ, et al: Wedge resection versus lobectomy for stage I (Tl NO MO) non-small-cell lung cancer. J Thorac Cardiovasc Surg 113:691-700, 1997.
23. Gauden SJ, Tripcony L: The curative treatment by radiation therapy alone of stage I non-small cell clung cancer in a geriatric population. Lung Cancer 32:71-79, 2001.
24. Rosenzweig KE, Dladla N, Schindelheim R, et al: Three-dimensional conformal radiation therapy (3D-CRT) for early-stage non-small cell lung cancer. Clin Lung Cancer 3:141-144, 2001.
25. Gilson J, Glassman D, Bockowski P et al: Body sterotactic radiosurgery for primary extracranial tumors (Proc Am Soc Clin Oncol 20:325a, 2001.
26. Furuse K, Fukuoka M, Kawahara M, et al: Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage HI non-small-cell lung cancer. J Clin Oncol 17:2692-2699, 1999.
27. Komaki R, Seiferheld W, Curran W, et al: Sequential vs concurrent chemotherapy and radiation therapy for inoperable non-small cell lung cancer (NSCLC): Analysis of failures in a phase III study (RTOG 9410). Int J Radial Oncol Biol Phys 48:113, 2000.
28. Langer CJ, Hsu C, Curran W, et al: Do elderly patients with locally advanced non- small cell lung cancer benefit from combined modality therapy? A secondary analysis of RTOG. Int J Radial Oncol Biol Phys 51:20-21, 2001.
29. Sause W, Kolesar P, Taylor S, et al: Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer. Chest 117:358-364, 2000.
30. Lau DH, Crowley JJ, Gandara DR, et al: Southwest Oncology Group phase II trial of concurrent carboplatin, etoposide, and radiation for poor-risk stage III non-small-cell lung cancer. J Clin Oncol 16:3078-3081, 1998.
31. Numico G, Russi E, Merlano M: Best supportive care in non-small cell lung cancer: Is there a role for radiotherapy and chemotherapy? Lung Cancer 32:213-226, 2001.
32. Bunn PA Jr, Kelly K: New chemothera- peutic agents prolong survival and improve quality of life in non-small cell lung cancer: A review of the literature and future directions. Clin Cancer Res 5:1087-1100, 1998.
33. Langer CJ, Manola J, Bernardo P, et al: Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: Implications of Eastern Cooperative Oncology Group 5592, a randomized trial. J Natl Cancer Inst 6:173-181, 2002.
34. Kelly K, Giarritta S, Hayes S, et al: Should older patients (pts) receive combination chemotherapy for advanced stage non- small cell lung cancer (NSCLC)? An analysis of Southwest Oncology trials 9509 and 9308 (Proc Am Soc Clin Oncol 20:329a, 2001.
35. Hensing TA, Socinski MA, Schell MJ, et al: Age does not alter toxicity or survival for patients (pts) with stage IIIB/IV non-small cell lung cancer (NSCLC) treated with carboplatin (C) and paclitaxel (P) (Proc Am Soc Clin Oncol 20:346a, 2001.
36. The Elderly Lung Cancer Vinorelbine Italian Study Group: Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer. J Natl Cancer Inst 91:66-72, 1999.
37. Gridelli C, Perrone F, Cigolari Si et al: The MILES (Multicenter Italian Lung Cancer in the Elderly Study) phase III trial: Gemcitabine + vinorelbine. vs vinorelbine vs gemcitabine in elderly advanced NSCLC patients (abstract 1230) (Proc Am Soc Clin Oncol 20:308a, 2001.
38. Frasci G, Lorusso V, Panza N, et al: Gemcitabine plus vinorelbine vs vinorelbine alone in elderly patients with advanced non-small-cell lung cancer. J Clin Oncol 18:2529-2536, 2000.
39. Fidias P, Supko JG, Martins R, et al: A phase II study of weekly paclitaxel in elderly patients with advanced non-small-cell lung cancer. Clin Cancer Res 7:3942-3949, 2001.